Immuneering Corp
Ticker: 1790340
values in millions
Revenue & Profit Trend
in millionsRevenueExpenditureNet Profit
Margin Trend
percentageOPM %NPM %
| Period | Q3 FY2022 | Q3 FY2022 | Q2 FY2022 | Q2 FY2022 | Q1 FY2022 | Q1 FY2022 | Q3 FY2021 | Q2 FY2021 |
|---|---|---|---|---|---|---|---|---|
| INCOME | ||||||||
| Revenue | 0.04+0.0% | 0.04-55.6% | 0.09+0.0% | 0.09-50.0% | 0.18+0.0% | 0.18-62.5% | 0.48-27.3% | 0.66 |
| Total Income | 0.04+0.0% | 0.04-55.6% | 0.09+0.0% | 0.09-50.0% | 0.18+0.0% | 0.18-62.5% | 0.48-27.3% | 0.66 |
| EXPENSES | ||||||||
| Expenditure | 13.23+0.0% | 13.23+12.7% | 11.74+0.0% | 11.74-10.5% | 13.11+0.0% | 13.11+45.2% | 9.03+4.4% | 8.65 |
| PROFIT | ||||||||
| Net Profit | -12.84+0.0% | -12.84-11.4% | -11.53+0.0% | -11.53+10.6% | -12.90+0.0% | -12.90-51.2% | -8.53-6.8% | -7.99 |
| KEY METRICS | ||||||||
| OPM % | -100.00% | -100.00% | -100.00% | -100.00% | -100.00% | -100.00% | -100.00% | -100.00% |
| NPM % | -100.00% | -100.00% | -100.00% | -100.00% | -100.00% | -100.00% | -100.00% | -100.00% |
| EPS | -0.49+0.0% | -0.49-11.4% | -0.44+0.0% | -0.44+10.2% | -0.49+0.0% | -0.49-4.3% | -0.47+70.8% | -1.61 |
Corporate Events
Board MeetingIMRX
202616Jul
Board Meeting
CFO Appointment — Andrew Gengos appointed as Chief Financial…
SEC Filing ↗ Board MeetingIMRX
202611Jun
Board Meeting
Annual Meeting of Stockholders to elect two Class II directo…
SEC Filing ↗ Board MeetingIMRX
202611Jun
Board Meeting
CFO Appointment — Andrew Gengos appointed as Chief Financial…
SEC Filing ↗